Lars Fruergaard Jørgensen is a Danish businessman and has been the chief executive of Novo Nordisk since January 2017. He is the chairman of the European Federation of Pharmaceutical Industries and Associations. From Wikipedia
Lars Fruergaard Jørgensen will remain temporarily to ensure a smooth transition as the company faces intensified competition and market pressures.
